We're thrilled to share that @LifebitAI will be exhibiting at The Festival of Genomics and Biodata in London this January! Check out their booth at the UK’s largest life sciences event, register now: https://t.co/1Ccb3LCP1o #FOG2026#genomics#biodata
We’re live at #BioTechX Europe 2025 in Basel.
📍 Visit us at Stand 662 to meet the Lifebit team, talk data-driven discovery, and see how we’re enabling secure, collaborative research for the future of precision medicine.
#Lifebit#BioTech#PrecisionMedicine#AIinHealthcare
We’re heading to #BioTechX Europe 2025 in Basel next week (6–8 Oct).
Find us at Stand 662 — meet our team, discover how Lifebit powers secure, collaborative data solutions, and grab a coffee while we chat about the future of precision medicine.
#PrecisionMedicine#LifeSciences
We’re live at #GERS2025.
At 14:10 BST, catch our CEO Dr Maria Dunford on the Showcase Stage presenting:
AI in TREs: Harmonised Data, Rapid Target Discovery & Democratised Genomic Insights
@GenomicsEngland
Details: https://t.co/g2s5CFMfgE
24 hours to go until the @GenomicsEngland Research Summit.
We’re looking forward to connecting with leaders in healthcare and life sciences to explore the future of genomic medicine.
Check the full details here: https://t.co/tWjMVI8Pmu
#GERS2025
We’re exhibiting at the @GenomicsEngland Research Summit on 17 June!
Join us in London to explore the latest in genomics and how we’re shaping the future of healthcare — from faster diagnoses to personalised treatments.
Register for the event at : https://t.co/Mkm0VOPePG
#GERS2025
The #EHDS is here — and Europe needs secure, interoperable TREs to make it work.
We dive into the EOSC-ENTRUST Policy Brief + Lifebit's role in building the future of trusted, federated research infrastructure.
Read more: https://t.co/A85JlJJDAd
#genomics#healthdata#EOSC
🚀 Lifebit’s federated TREs are powering global precision medicine!
A new study names Lifebit in key initiatives, including Genomics England, Singapore’s TRUST, & the Danish National Genome Center.
🔗 Read more: https://t.co/oCOGryebkk
#Genomics#AI#PrecisionMedicine#Lifebit
How do you turn real-world data into compliant, high-impact data products? Overcome challenges in quality, privacy & compliance.
Learn more: https://t.co/yFTOlM3BCO
#RWD#DataProducts#HealthcareTech#Lifebit
🌍💙 Today is #RareDiseaseDay – a day to shine a light on estimated 300M+ people worldwide living with a rare disease. There are over 6,000 rare diseases, but most remain poorly understood and lack effective therapies
Imagine waiting years for a diagnosis—facing endless tests, uncertainty, and, too often, no treatment at all.
🔬 Many rare diseases remain poorly understood and lack effective therapies due to small, fragmented datasets and strict privacy regulations impeding data sharing, which is critical for research.
At Lifebit, our mission is to make biomedical data accessible and actionable wherever it resides. The Lifebit Federated Platform enables researchers to securely analyze genomic data without moving sensitive patient information, so researchers can generate discoveries while protecting privacy. 🧬💡
Because behind every dataset is a person, a family, a life waiting for answers and hope. Let’s push the boundaries of research—together.
#Genomics #FederatedLearning #PrecisionMedicine #RareDiseaseResearch #Lifebit
🌟 New Blog: The Application of Data Lakehouses in Life Sciences 🌟
How can data lakehouses revolutionize life sciences? By harmonizing diverse datasets, fueling AI insights, and future-proofing infrastructure for drug discovery and beyond.
Dive into the blog to explore:
🔹 Key benefits of data lakehouses
🔹 Applications in genomics, clinical trials & precision medicine
🔹 Lifebit’s Trusted Data Lakehouse™ advantage
🔗 https://t.co/xNYOypiBh5
#DataLakehouse #AI #PrecisionMedicine #DrugDiscovery #Lifebit
How can #Pharma optimize #RealWorldEvidence (RWE) to accelerate drug discovery and improve patient outcomes?
Our latest blog dives into the key challenges, strategies, and technologies driving the future of RWE.
Read more: https://t.co/1bVZKBM2DK
#ClinicalTrials#LifeSciences #DrugDiscovery